1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
• 1.2.1 Global Pharmaceutical Formulation Development Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Oral

1.2.3 External Use

1.3 Market by Application

1.3.1 Global Pharmaceutical Formulation Development Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Enterprise

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Pharmaceutical Formulation Development Market Perspective (2017-2028)
• 2.2 Pharmaceutical Formulation Development Growth Trends by Region
• 2.2.1 Pharmaceutical Formulation Development Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Pharmaceutical Formulation Development Historic Market Size by Region (2017-2022)

2.2.3 Pharmaceutical Formulation Development Forecasted Market Size by Region (2023-2028)

2.3 Pharmaceutical Formulation Development Market Dynamics

2.3.1 Pharmaceutical Formulation Development Industry Trends

2.3.2 Pharmaceutical Formulation Development Market Drivers

2.3.3 Pharmaceutical Formulation Development Market Challenges

2.3.4 Pharmaceutical Formulation Development Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmaceutical Formulation Development Players by Revenue
• 3.1.1 Global Top Pharmaceutical Formulation Development Players by Revenue (2017-2022)

3.1.2 Global Pharmaceutical Formulation Development Revenue Market Share by Players (2017-2022)

3.2 Global Pharmaceutical Formulation Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmaceutical Formulation Development Revenue

3.4 Global Pharmaceutical Formulation Development Market Concentration Ratio

3.4.1 Global Pharmaceutical Formulation Development Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Formulation Development Revenue in 2021

3.5 Pharmaceutical Formulation Development Key Players Head office and Area Served

3.6 Key Players Pharmaceutical Formulation Development Product Solution and Service

3.7 Date of Enter into Pharmaceutical Formulation Development Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Formulation Development Breakdown Data by Type

• 4.1 Global Pharmaceutical Formulation Development Historic Market Size by Type (2017-2022)
• 4.2 Global Pharmaceutical Formulation Development Forecasted Market Size by Type (2023-2028)

5 Pharmaceutical Formulation Development Breakdown Data by Application

• 5.1 Global Pharmaceutical Formulation Development Historic Market Size by Application (2017-2022)
• 5.2 Global Pharmaceutical Formulation Development Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Pharmaceutical Formulation Development Market Size (2017-2028)
• 6.2 North America Pharmaceutical Formulation Development Market Size by Country (2017-2022)
• 6.3 North America Pharmaceutical Formulation Development Market Size by Country (2023-2028)
• 6.4 United States
• 6.5 Canada

7 Europe

• 7.1 Europe Pharmaceutical Formulation Development Market Size (2017-2028)
• 7.2 Europe Pharmaceutical Formulation Development Market Size by Country (2017-2022)
• 7.3 Europe Pharmaceutical Formulation Development Market Size by Country (2023-2028)
• 7.4 Germany
• 7.5 France
• 7.6 U.K.
• 7.7 Italy
• 7.8 Russia
• 7.9 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Pharmaceutical Formulation Development Market Size (2017-2028)
• 8.2 Asia-Pacific Pharmaceutical Formulation Development Market Size by Country (2017-2022)
• 8.3 Asia-Pacific Pharmaceutical Formulation Development Market Size by Country (2023-2028)
• 8.4 China
• 8.5 Japan
• 8.6 South Korea
• 8.7 Southeast Asia
• 8.8 India
• 8.9 Australia

9 Latin America

• 9.1 Latin America Pharmaceutical Formulation Development Market Size (2017-2028)
• 9.2 Latin America Pharmaceutical Formulation Development Market Size by Country (2017-2022)
• 9.3 Latin America Pharmaceutical Formulation Development Market Size by Country (2023-2028)
• 9.4 Mexico
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Pharmaceutical Formulation Development Market Size (2017-2028)
• 10.2 Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2017-2022)
• 10.3 Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2023-2028)
• 10.4 Turkey
• 10.5 Saudi Arabia
• 10.6 UAE

11 Key Players Profiles

• 11.1 LGM Pharma
• 11.1.1 LGM Pharma Company Detail

11.1.2 LGM Pharma Business Overview

11.1.3 LGM Pharma Pharmaceutical Formulation Development Introduction

11.1.4 LGM Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.1.5 LGM Pharma Recent Development

11.2 Dalton Pharma Services

11.2.1 Dalton Pharma Services Company Detail

11.2.2 Dalton Pharma Services Business Overview

11.2.3 Dalton Pharma Services Pharmaceutical Formulation Development Introduction

11.2.4 Dalton Pharma Services Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.2.5 Dalton Pharma Services Recent Development

11.3 Recipharm

11.3.1 Recipharm Company Detail

11.3.2 Recipharm Business Overview

11.3.3 Recipharm Pharmaceutical Formulation Development Introduction

11.3.4 Recipharm Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.3.5 Recipharm Recent Development

11.4 Aurigene Pharmaceutical Services

11.4.1 Aurigene Pharmaceutical Services Company Detail

11.4.2 Aurigene Pharmaceutical Services Business Overview

11.4.3 Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Introduction

11.4.4 Aurigene Pharmaceutical Services Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.4.5 Aurigene Pharmaceutical Services Recent Development

11.5 Coriolis Pharma

11.5.1 Coriolis Pharma Company Detail

11.5.2 Coriolis Pharma Business Overview

11.5.3 Coriolis Pharma Pharmaceutical Formulation Development Introduction

11.5.4 Coriolis Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.5.5 Coriolis Pharma Recent Development

11.6 Intertek

11.6.1 Intertek Company Detail

11.6.2 Intertek Business Overview

11.6.3 Intertek Pharmaceutical Formulation Development Introduction

11.6.4 Intertek Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.6.5 Intertek Recent Development

11.7 Quay Pharma

11.7.1 Quay Pharma Company Detail

11.7.2 Quay Pharma Business Overview

11.7.3 Quay Pharma Pharmaceutical Formulation Development Introduction

11.7.4 Quay Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.7.5 Quay Pharma Recent Development

11.8 Lonza

11.8.1 Lonza Company Detail

11.8.2 Lonza Business Overview

11.8.3 Lonza Pharmaceutical Formulation Development Introduction

11.8.4 Lonza Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.8.5 Lonza Recent Development

11.9 Ardena

11.9.1 Ardena Company Detail

11.9.2 Ardena Business Overview

11.9.3 Ardena Pharmaceutical Formulation Development Introduction

11.9.4 Ardena Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.9.5 Ardena Recent Development

11.10 Kemwell

11.10.1 Kemwell Company Detail

11.10.2 Kemwell Business Overview

11.10.3 Kemwell Pharmaceutical Formulation Development Introduction

11.10.4 Kemwell Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.10.5 Kemwell Recent Development

11.11 SGS

11.11.1 SGS Company Detail

11.11.2 SGS Business Overview

11.11.3 SGS Pharmaceutical Formulation Development Introduction

11.11.4 SGS Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.11.5 SGS Recent Development

11.12 Syngene International

11.12.1 Syngene International Company Detail

11.12.2 Syngene International Business Overview

11.12.3 Syngene International Pharmaceutical Formulation Development Introduction

11.12.4 Syngene International Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.12.5 Syngene International Recent Development

11.13 Piramal Pharma Solutions

11.13.1 Piramal Pharma Solutions Company Detail

11.13.2 Piramal Pharma Solutions Business Overview

11.13.3 Piramal Pharma Solutions Pharmaceutical Formulation Development Introduction

11.13.4 Piramal Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.13.5 Piramal Pharma Solutions Recent Development

11.14 Pharma Mo Ltd

11.14.1 Pharma Mo Ltd Company Detail

11.14.2 Pharma Mo Ltd Business Overview

11.14.3 Pharma Mo Ltd Pharmaceutical Formulation Development Introduction

11.14.4 Pharma Mo Ltd Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.14.5 Pharma Mo Ltd Recent Development

11.15 Metrics Contract Services

11.15.1 Metrics Contract Services Company Detail

11.15.2 Metrics Contract Services Business Overview

11.15.3 Metrics Contract Services Pharmaceutical Formulation Development Introduction

11.15.4 Metrics Contract Services Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.15.5 Metrics Contract Services Recent Development

11.16 COREALIS Pharma

11.16.1 COREALIS Pharma Company Detail

11.16.2 COREALIS Pharma Business Overview

11.16.3 COREALIS Pharma Pharmaceutical Formulation Development Introduction

11.16.4 COREALIS Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.16.5 COREALIS Pharma Recent Development

11.17 Element Materials Technology

11.17.1 Element Materials Technology Company Detail

11.17.2 Element Materials Technology Business Overview

11.17.3 Element Materials Technology Pharmaceutical Formulation Development Introduction

11.17.4 Element Materials Technology Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.17.5 Element Materials Technology Recent Development

11.18 Adare Pharma Solutions

11.18.1 Adare Pharma Solutions Company Detail

11.18.2 Adare Pharma Solutions Business Overview

11.18.3 Adare Pharma Solutions Pharmaceutical Formulation Development Introduction

11.18.4 Adare Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.18.5 Adare Pharma Solutions Recent Development

11.19 Singota Solutions

11.19.1 Singota Solutions Company Detail

11.19.2 Singota Solutions Business Overview

11.19.3 Singota Solutions Pharmaceutical Formulation Development Introduction

11.19.4 Singota Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.19.5 Singota Solutions Recent Development

11.20 Creative Biolabs

11.20.1 Creative Biolabs Company Detail

11.20.2 Creative Biolabs Business Overview

11.20.3 Creative Biolabs Pharmaceutical Formulation Development Introduction

11.20.4 Creative Biolabs Revenue in Pharmaceutical Formulation Development Business (2017-2022)

11.20.5 Creative Biolabs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
• 13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

Industry Insights
The global Pharmaceutical Formulation Development market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Oral accounting for % of the Pharmaceutical Formulation Development global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.

China Pharmaceutical Formulation Development market size is valued at US$ million in 2021, while the North America and Europe Pharmaceutical Formulation Development are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pharmaceutical Formulation Development landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Formulation Development market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Formulation Development market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Formulation Development market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Formulation Development market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Pharmaceutical Formulation Development market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Pharmaceutical Formulation Development Breakdown Data by Type

Oral

External Use

Pharmaceutical Formulation Development Breakdown Data by Application

Hospital

Enterprise

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

LGM Pharma

Dalton Pharma Services

Recipharm

Aurigene Pharmaceutical Services

Coriolis Pharma

Intertek

Quay Pharma

Lonza

Ardena

Kemwell

SGS

Syngene International

Piramal Pharma Solutions

Pharma Mo Ltd

Metrics Contract Services

COREALIS Pharma

Element Materials Technology

Adare Pharma Solutions

Singota Solutions

Creative Biolabs

Frequently Asked Questions

What factors will challenge the Pharmaceutical Formulation Development market growth?

Which end-use segment will expand at the fastest CAGR in the Pharmaceutical Formulation Development market?

Which are the emerging players in the Pharmaceutical Formulation Development market?

How concentrated is the Pharmaceutical Formulation Development market?

Which factors are positively contributing to the Pharmaceutical Formulation Development market growth?

Which are the novel product innovations in the Pharmaceutical Formulation Development market?

Which product segment will emerge as the most lucrative in the Pharmaceutical Formulation Development market?

Which factors are increasing the competition in the Pharmaceutical Formulation Development market?

Which are the strategic measures taken by the Pharmaceutical Formulation Development industry players?

Which region will witness inactive growth during the forecast period?

What key trends are likely to emerge in the Pharmaceutical Formulation Development market in the coming years?